Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Interleukin-18 inhibitor PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Diabetes Mellitus 2 D003920 ClinicalTrials
Behcet Syndrome 2 D001528 ClinicalTrials
Inflammatory Bowel Diseases 1 D015212 ClinicalTrials
Crohn Disease 1 D003424 ClinicalTrials
Dermatitis, Atopic 1 D003876 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2109606